Discover
ITOS
iTeos Therapeutics, Inc.
10.15
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 32.16% | |
| 1y | -40.82% |
10.15
day range
10.15
52 week range
| Open | Prev Close | 10.15 | Low | 10.15 | High | 10.15 | Mkt Cap | N/A | |
| Vol | 0.00 | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -1.26 |
| Beta | 1.39 | Short Ratio | 3.66 | Inst. Own | 103.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 25.00 |
| Income Statement | |||
| Operating Expenses | 83.79M | ||
| Research and Development Expense | 57.28M | ||
| Selling, General and Administrative Expense | 10.18M | ||
| Operating Income | -83.79M | ||
| Income Tax Expense | 1.67M | ||
| Net Income | -78.73M | ||
| Net Income Common Stock | -78.73M | ||
| Net Income Common Stock (USD) | -78.73M | ||
| Consolidated Income | -78.73M | ||
| Earnings per Basic Share | -1.81 | ||
| Earnings per Basic Share (USD) | -1.81 | ||
| Earnings per Diluted Share | -1.81 | ||
| Earning Before Interest & Taxes (EBIT) | -77.06M | ||
| Earning Before Interest & Taxes (USD) | -77.06M | ||
| Weighted Average Shares | 43.56M | ||
| Weighted Average Shares Diluted | 43.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 208.14M | ||
| Cash and Equivalents (USD) | 208.14M | ||
| Investments | 382.22M | ||
| Investments Current | 307.61M | ||
| Investments Non-Current | 74.61M | ||
| Trade and Non-Trade Receivables | 475.00K | ||
| Current Assets | 528.99M | ||
| Property, Plant & Equipment Net | 10.30M | ||
| Total Assets | 623.08M | ||
| Debt Current | 1.52M | ||
| Total Debt | 5.13M | ||
| Current Liabilities | 70.27M | ||
| Debt Non-Current | 3.61M | ||
| Total Liabilities | 129.28M | ||
| Accumulated Retained Earnings (Deficit) | -123.12M | ||
| Accumulated Other Comprehensive Income | -16.19M | ||
| Shareholders Equity | 493.80M | ||
| Shareholders Equity (USD) | 493.80M | ||
| Assets Non-Current | 94.09M | ||
| Total Debt (USD) | 5.13M | ||
| Deferred Revenue | 1.48M | ||
| Liabilities Non-Current | 59.01M | ||
| Trade and Non-Trade Payables | 6.25M | ||
| Tax Assets | 10.03M | ||
| Tax Liabilities | 48.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 340.00K | ||
| Net Cash Flow from Financing | 4.49M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 51.29M | ||
| Capital Expenditure | -283.00K | ||
| Issuance (Purchase) of Equity Shares | 4.49M | ||
| Net Cash Flow from Investing | 86.95M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 87.24M | ||
| Net Cash Flow from Operations | -42.45M | ||
| Effect of Exchange Rate Changes on Cash | 2.29M | ||
| Share Based Compensation | 5.88M | ||